A novel cell therapy is safe and effective in patients with drug-resistant mesial temporal lobe epilepsy and could eventually offer an alternative intervention.

Patients with functional seizures face higher mortality risk than the general population but lower risk than those with epileptic seizures.

NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution ...

NeuroPace, Inc. , a medical device company focused on transforming the lives of people living with drug resistant epilepsy, today announced a major milestone in its clinical evidence program with the ...

The red-and-green macaw was once widely found throughout Brazil, but deforestation and illegal capture for the pet trade ...

In an incident that has left Bengaluru residents furious, six young children–none appearing older than 10-12 years, were spotted riding a single scooter on a crowded road on the morning of 26 ...

Johnson & Johnson today announced findings from the first network meta-analysis (NMA) comparing CAPLYTA® (lumateperone) to FDA-approved atypical antipsychotics for add-on treatment of major depressive ...

Bacterial meningitis acts fast: What may start as mild, cold-like symptoms can turn into a life-threatening situation in less than 24 hours. Ultimately, the disease - which is most common in teens, as ...

Our definition of homelessness leaves out many single adults who are sleeping in cars, couch-surfing or leaving prison or hospital without a home, writes Dermot Kavanagh of Cork Simon ...

After a rare disease took her hearing, McKinnon Galloway had to suddenly adapt - amid medical trauma, personal loss and relentless upheaval.

A young man with autism in Cuba is battling a severe bacterial infection that is rapidly destroying his tissues, yet he has ...